CorMedix (CRMD) Capital Expenditures Growth (5y) (2015 - 2025)
CorMedix (CRMD) Capital Expenditures Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | CorMedix | 4.95 Mn | -150.25 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 86.09% |
| Sep 30, 2025 | 87.89% |
| Jun 30, 2025 | 42.77% |
| Mar 31, 2025 | 0.52% |
| Dec 31, 2024 | 1.46% |
| Sep 30, 2024 | 17.20% |
| Jun 30, 2024 | 58.24% |
| Mar 31, 2024 | 26.11% |
| Sep 30, 2023 | -0.81% |
| Jun 30, 2023 | 476.36% |
| Mar 31, 2023 | -17.32% |
| Dec 31, 2022 | 0.54% |
| Sep 30, 2022 | 27.47% |
| Jun 30, 2022 | 38.66% |
| Mar 31, 2022 | 16.70% |
| Dec 31, 2021 | 180.58% |
| Sep 30, 2021 | 71.02% |
| Jun 30, 2021 | 23.66% |
| Dec 31, 2020 | 115.72% |
| Sep 30, 2020 | 636.02% |